![Andrew Saik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Saik
Direttore Finanziario/CFO presso
ARVINAS, INC.
Patrimonio netto: 2 M $ in data 31/07/2026
Profilo
Mr. Andrew R.
Saik is an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. and a Chief Financial Officer & Treasurer at Arvinas, Inc. He is on the Board of Directors at Milestone Pharmaceuticals, Inc. Mr. Saik was previously employed as a Chief Financial Officer by Intercept Pharmaceuticals, Inc., a Chief Financial Officer & Treasurer by Menlo Therapeutics, Inc., a Chief Financial Officer & Treasurer by VYNE Therapeutics, Inc., a Chief Financial Officer & Director by PDS Biotechnology Corp., a Chief Financial Officer by Edge Therapeutics, Inc., a Chief Financial Officer by Vertice Pharma LLC, a Chief Financial Officer by Auxilium Pharmaceuticals LLC, a Treasurer & Senior Vice President-Finance by Endo Health Solutions, Inc., a Senior Vice President-Finance by Valeant Pharmaceuticals International Corp., and a Finance Manager by nexgenIX, Inc. He received his undergraduate degree from the University of California, Los Angeles and an MBA from the University of Southern California.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ARVINAS, INC. 0,29% | 24/06/2026 | 187.432 ( 0,29% ) | 2 M $ | 31/07/2026 |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Posizioni attive di Andrew Saik
| Società | Posizione | Inizio |
|---|---|---|
| ARVINAS, INC. | Direttore Finanziario/CFO | 24/06/2024 |
| MILESTONE PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 14/07/2024 |
Precedenti posizioni note di Andrew Saik
| Società | Posizione | Fine |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/06/2024 |
| YARROW BIOSCIENCE, INC. | Direttore Finanziario/CFO | 18/06/2021 |
| PDS BIOTECHNOLOGY CORPORATION | Direttore Finanziario/CFO | 20/03/2020 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Direttore Finanziario/CFO | 01/03/2019 |
Vertice Pharma LLC
 Vertice Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes branded & generic prescription medicines | Direttore Finanziario/CFO | 01/07/2017 |
Formazione di Andrew Saik
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
70
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures analgesics pharmaceutical products | Health Technology |
nexgenIX, Inc.
 nexgenIX, Inc. Packaged SoftwareTechnology Services Provides business software solutions | Technology Services |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Vertice Pharma LLC
Vertice Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes branded & generic prescription medicines | Health Technology |
PDS Biotechnology Corp.
 PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
VYNE Therapeutics, Inc.
 VYNE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
